Scaling Patient Engagement Measurement in Biotech Without Big- Pharma Resources

  • Prioritizing high-value metrics that matter to leadership, partners, and regulators
  • Embedding lightweight tracking into existing workflows to avoid measurement fatigue
  • Leveraging outsourced partners, CROs, and patient groups to extend capacity
  • Preparing early-stage measurement foundations that scale as the organization grows
  • Tracking the long-term benefits of patient engagement to demonstrate value to the organization over time